Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus.

A series of tryptamine derivatives were synthesized and evaluated for their anti-hepatitis B virus (HBV) activity and cytotoxicity in the HepG2.2.15 cell line.